Expression of ERCC1, Bcl-2, MT and their clinical significance in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
Artículo
Acceso abierto
Artículo
SEDICI UNLP
The aim of this study was to determine the prognostic value of expression of Excision Repair
Cross-complementation Group 1 (ERCC1), B cell lymphoma/lewkmia-2 (Bcl-2) and metallothionein (MT)
by immunohistochemically st...
Idioma en
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access